Table 5.

Management of kidney transplant recipients with coronavirus disease 2019

Management Approach
Mild patients not requiring hospital admission
1. Continuation of current immunosuppression with calcineurin inhibitor and prednisone
2. Decrease in antimetabolite dose (25%–100%)
3. Monoclonal neutralizing antibody treatment (LY-CoV555 or REGN-COV2)
Moderate patients requiring hospital admission
1. Continuation of current immunosuppression with calcineurin inhibitor treatment with 25%–50% dose reduction
2. Dexamethasone 6 mg daily for 5–10 days
3. Hold antimetabolite
Severe patients requiring intensive care unit admission
1. Holding calcineurin inhibitor and antimetabolite
2. Dexamethasone 6 mg daily for 5–10 days

REGN-COV2, casirivimab and imdevimab.